Baird Maintains Neutral on Medpace Holdings, Raises Price Target to $624

Benzinga · 3d ago
Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $547 to $624.